Distinct predictive biomarker candidates for response to anti-CTLA-4 and anti-PD-1 immunotherapy in melanoma patients

Abstract Background While immune checkpoint blockade has greatly improved clinical outcomes in diseases such as melanoma, there remains a need for predictive biomarkers to determine who will likely benefit most from which therapy. To date, most biomarkers of response have been identified in the tumo...

Descripció completa

Dades bibliogràfiques

Autors principals:	Priyanka B. Subrahmanyam, Zhiwan Dong, Daniel Gusenleitner, Anita Giobbie-Hurder, Mariano Severgnini, Jun Zhou, Michael Manos, Lauren M. Eastman, Holden T. Maecker, F. Stephen Hodi
Format:	Artigo
Idioma:	Inglês
Publicat:	BMJ Publishing Group 2018-03-01
Col·lecció:	Journal for ImmunoTherapy of Cancer
Accés en línia:	http://link.springer.com/article/10.1186/s40425-018-0328-8
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!